BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8284002)

  • 41. Ranitidine and recurrent hemorrhage from duodenal ulcer.
    Loffeld RJ; van der Putten AB
    N Engl J Med; 1994 Jul; 331(1):53; author reply 53-4. PubMed ID: 8202110
    [No Abstract]   [Full Text] [Related]  

  • 42. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
    ten Wolde S; Dijkmans BA; Janssen M; Hermans J; Lamers CB
    Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of duodenal ulcer relapse with ranitidine.
    Mekel RC; den Boer DJ
    S Afr Med J; 1985 Sep; 68(6):385-6. PubMed ID: 3898417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
    Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
    Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two year maintenance treatment of duodenal ulcer disease with ranitidine 150 mg: a prospective multicentre randomised study. GEMUD (Groupe d'Etude de la Maladie UlcĂ©reuse DuodĂ©nale).
    Ruszniewski P; Slama A; Pappo M; Mignon M
    Gut; 1993 Dec; 34(12):1662-5. PubMed ID: 8282251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine.
    Penston JG; Dixon JS; Boyd EJ; Wormsley KG
    Aliment Pharmacol Ther; 1993 Jun; 7(3):259-65. PubMed ID: 8364131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists.
    Boyd EJ; Penston JG; Wormsley KG
    Scand J Gastroenterol Suppl; 1990; 178():72-8. PubMed ID: 2277972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers.
    Sue SO; Dawson DM; Brown JA; Wood DR; Kleoudis CS
    Clin Ther; 1996; 18(6):1175-83. PubMed ID: 9001834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bleeding duodenal ulcer. Role of gastric acid hypersecretion.
    Collen MJ; Kalloo AN; Sheridan MJ
    Dig Dis Sci; 1993 Feb; 38(2):269-75. PubMed ID: 8093870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence.
    Bardhan KD; Morris P; Hinchliffe RF; Saunders JH; MacDougall BR; Bold JM; Freeman PR
    Aliment Pharmacol Ther; 1989 Oct; 3(5):489-97. PubMed ID: 2518862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of recurrent ulcer bleeding, a multicentre study of the effect of ranitidine and trimipramine over one year.
    Stave R; Myren J; Osnes M
    Scand J Gastroenterol Suppl; 1986; 124():55-62. PubMed ID: 3334187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duodenal ulcer healing after presentation with haemorrhage.
    Murray WR; Laferla G; Cooper G; Archibald M
    Gut; 1986 Nov; 27(11):1387-9. PubMed ID: 3539708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.
    Lauritsen K; Havelund T; Laursen LS; Bytzer P; Kjaergaard J; Rask-Madsen J
    Br Med J (Clin Res Ed); 1987 Apr; 294(6577):932-4. PubMed ID: 3107660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. A 1-year follow-up study.
    Bytzer P; Lauritsen K; Rask-Madsen J
    Scand J Gastroenterol; 1986 Aug; 21(6):765-8. PubMed ID: 3749811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence of duodenal ulceration in patients on maintenance ranitidine.
    Marks IN; Wright JP; Girdwood AH; Lucke W
    S Afr Med J; 1984 Jun; 65(25):1010-1. PubMed ID: 6328686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled clinical trial of ranitidine in bleeding peptic ulcer.
    Gray BN; De Zwart J; Andrewarthur L; Crowley S; Kamm M; Watson K
    Aust N Z J Surg; 1986 Sep; 56(9):723-7. PubMed ID: 3541882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary supplementation with pectin in the maintenance treatment of duodenal ulcer. A controlled study.
    Kang JY; Tay HH; Guan R; Math MV; Yap I; Labrooy SJ
    Scand J Gastroenterol; 1988 Jan; 23(1):95-9. PubMed ID: 3278367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ranitidine maintenance therapy in the prevention of duodenal ulceration; a comparison of 150 mg at night with 300 mg at night.
    McDougle AM; Lancaster-Smith MJ; Higson DL
    Aliment Pharmacol Ther; 1995 Jun; 9(3):287-91. PubMed ID: 7654891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients.
    Chan KH; Lai EC; Tuen H; Ngan JH; Mok F; Fan YW; Fung CF; Yu WC
    J Neurosurg; 1995 Mar; 82(3):413-7. PubMed ID: 7861219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cimetidine and ranitidine may not cross-react to cause thrombocytopenia.
    Shalev O; Seror D
    J Intern Med; 1991 Jul; 230(1):87-8. PubMed ID: 2066715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.